Provided by Tiger Trade Technology Pte. Ltd.

Immunovant, Inc.

44.37
+0.02000.05%
Post-market: 43.73-0.6392-1.44%19:30 EDT
Volume:846.60K
Turnover:37.69M
Market Cap:9.16B
PE:-15.75
High:45.12
Open:44.85
Low:44.08
Close:44.35
52wk High:45.42
52wk Low:14.47
Shares:206.40M
Float Shares:89.57M
Volume Ratio:0.74
T/O Rate:0.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8178
EPS(LYR):-2.7716
ROE:-80.10%
ROA:-46.73%
PB:12.45
PE(LYR):-16.01

Loading ...

Earnings Flash (IMVT) Immunovant Posts Fiscal Q4 Net Loss $0.73 a Share, vs. FactSet Est of $0.59 Loss

MT Newswires Live
·
May 20

Immunovant Q4 EPS $(0.73) Misses $(0.60) Estimate

Benzinga Earnings
·
May 20

BRIEF-Immunovant Q4 Net Income USD -147.856 Million Vs. IBES Estimate USD -116.8 Million

Reuters
·
May 20

Immunovant Q4 net loss widens to $147.86 million

Reuters
·
May 20

Immunovant Q4 Basic EPS USD -0.73

THOMSON REUTERS
·
May 20

Immunovant Inc - Cash Balance Provides Runway to Potential Imvt-1402 Launch in GD

THOMSON REUTERS
·
May 20

Immunovant Provides Corporate Updates and Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2026

THOMSON REUTERS
·
May 20

Stock Track | Immunovant Soars 9.43% in Pre-Market on Improved Earnings Forecast

Stock Track
·
May 20

U.S. Earnings Preview: Before Market Open May 20

Dow Jones
·
May 20

A Look At Roivant Sciences (ROIV) Valuation As IMVT-1402 And Earnings Outlook Draw Investor Focus

Simply Wall St.
·
May 19

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 18

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 15

Earning Preview: Immunovant, Inc. this quarter’s revenue is expected to increase by 0%, and institutional views are bullish

Earnings Agent
·
May 14

Immunovant to report fourth-quarter, fiscal-year results, give business update on conference call

Reuters
·
May 12

Immunovant director Robert Graham Susman sells 2,502 shares for $67,988.34

Reuters
·
May 02

Analysts’ Top Healthcare Picks: Sandoz Group Ltd (SDZXF), Immunovant (IMVT)

TIPRANKS
·
Apr 28

Zura Bio names Marlyn Mathew principal financial, accounting officer after CFO exit

Reuters
·
Apr 24

Strengthening the Buy Case for IMVT-1402: Targeted Phase 3 Graves’ Disease Strategy and Reproducible Efficacy Support Commercial Potential

TIPRANKS
·
Apr 07

Immunovant CEO Eric Venker disposes of common shares worth $8.5 million

Reuters
·
Apr 04

Sector Update: Health Care Stocks Softer Thursday Afternoon

MT Newswires Live
·
Apr 03